Loading company…
Ruifu Pharmaceutical develops small molecule drugs using its cLNA research platform.
Founded in 2021, Ruifu Pharmaceutical Technology (Guangzhou) Co., Ltd. develops innovative small molecule drugs and has taken a Class 1 drug from research through market launch. It is based in Guangzhou, China. In February 2026, it raised pre-Series A funding led by Xietong Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in